TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 79 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $207,000 | 0.0% | 154,782 | -15.6% | 0.00% | – |
Q4 2018 | $207,000 | -43.1% | 183,337 | +217.7% | 0.00% | – |
Q4 2017 | $364,000 | -67.4% | 57,715 | -64.6% | 0.00% | -100.0% |
Q3 2017 | $1,117,000 | +620.6% | 163,266 | +650.1% | 0.00% | – |
Q2 2017 | $155,000 | +287.5% | 21,766 | +110.6% | 0.00% | – |
Q3 2016 | $40,000 | -73.2% | 10,334 | -70.2% | 0.00% | – |
Q2 2016 | $149,000 | -29.0% | 34,732 | -23.3% | 0.00% | – |
Q1 2016 | $210,000 | -77.0% | 45,279 | -63.1% | 0.00% | -100.0% |
Q3 2015 | $914,000 | -85.0% | 122,545 | -4.6% | 0.00% | -83.3% |
Q2 2015 | $6,095,000 | +73.6% | 128,462 | +34.1% | 0.01% | +50.0% |
Q1 2015 | $3,510,000 | +199.7% | 95,800 | +224.7% | 0.01% | +300.0% |
Q4 2014 | $1,171,000 | +302.4% | 29,500 | +102.1% | 0.00% | +100.0% |
Q3 2014 | $291,000 | +47.7% | 14,600 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $197,000 | – | 14,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |